Let's team up to tackle high drug costs. Competition is what makes markets work. It's what keeps prices down. So when brand pharmaceutical companies tilt the playing field, drugs become less affordable and less accessible. The bipartisan CREATES Act (S. 974/H.R. 2212) would level the field, saving patients billions.
White Paper - Renting Tribal Immunity to Evade IPR Review of Pharmaceutical Patents